Somasundaram K, MacLachlan T K, Burns T F, Sgagias M, Cowan K H, Weber B L, el-Deiry W S
Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Oncogene. 1999 Nov 11;18(47):6605-14. doi: 10.1038/sj.onc.1203284.
The hereditary breast and ovarian tumor suppressor BRCA1 can activate p53-dependent gene expression. We show here that BRCA1 increases p53 protein levels through a post-transcriptional mechanism. BRCA1-stabilized p53 has increased sequence-specific DNA-binding and transcriptional activity. BRCA1 does not stabilize p53 in p14ARF-deficient cells. A deletion mutant of BRCA1 which inhibits p53-dependent transcription confers resistance to topoisomerase II-targeted chemotherapy. Our results suggest that BRCA1 may trigger the p53 pathway through two potentially separate mechanisms: accumulation of p53 through a direct or indirect induction of p14ARF as well as direct transcriptional coactivation of p53. BRCA1 may also enhance chemosensitivity and repair of DNA damage through binding to and coactivation of p53.
遗传性乳腺癌和卵巢癌肿瘤抑制因子BRCA1可激活p53依赖的基因表达。我们在此表明,BRCA1通过转录后机制提高p53蛋白水平。BRCA1稳定的p53具有增强的序列特异性DNA结合和转录活性。BRCA1在p14ARF缺陷细胞中不能稳定p53。一种抑制p53依赖转录的BRCA1缺失突变体赋予对拓扑异构酶II靶向化疗的抗性。我们的结果表明,BRCA1可能通过两种潜在独立的机制触发p53途径:通过直接或间接诱导p14ARF积累p53以及p53的直接转录共激活。BRCA1还可能通过与p53结合和共激活来增强化学敏感性和DNA损伤修复。